| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.088 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.09 | 0.005 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.007 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.009 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |